ValiRx Share News (VAL)
VAL Share
VAL Share
VAL Share
VAL Share
VAL
VAL Share
VAL Level 2
VAL Live
VAL Broker
VAL Directors
VAL Financial
VAL
VAL Short
VAL
Last checked at -
Tue, 24th Sep 2019 12:40
(Alliance News) - Clinical stage biotechnology firm ValiRx PLC said on Tuesday it has received an HMRC research & development tax credit of GBP423,000.
The company said it continues to "carefully manage" its working capital position.
Shares in ValiRx were up 7.6% at 0.1667 pence in London on Tuesday.
By Lucy Heming; lucyheming@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
Valirx, the developer and producer of technology used in oncology therapeutics, has received positive results from the studies on one of its lung cancer treatments. The studies on treatment VAL401 were carried out by Valiseek, Valirx's joint venture company with Tangent Reprofiling, and demonstrate
Read more
Last checked at